Skip to main content
Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Financial Conglomerates
Sector Finance
Employees 210,000
CEO Ms. Jane Nind Fraser
Address 388 Greenwich Street , New York, NY 10013
Phone 1.212.559.1000
Website www.citigroup.com

Citigroup, Inc. is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Global Consumer Banking; Institutional Clients Group; and Corporate and Other. The Global Consumer Banking segment provides traditional banking services to retail customers through retail banking, including commercial banking, and Citi-branded cards and Citi retail services. The Institutional Clients Group segment provides corporate, institutional, public sector and high-net-worth clients around the world with a full range of wholesale banking products and services. This segment includes fixed income and equity sales and trading, foreign exchange, prime brokerage, derivative services, equity and fixed income research, corporate lending, investment banking and advisory services, private banking, cash management, trade finance and securities services. The Corporate and Other segment includes certain unallocated costs of global staff functions, other corporate expenses and unallocated global operations and technology expenses, Corporate Treasury, certain North America and international legacy consumer loan portfolios, other legacy assets and discontinued operations. The company was founded in 1812 and is headquartered in New York, NY.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
Citigroup, Inc. -12.15% 6.65%
Wells Fargo & Co. 10.50% 65.18%
Morgan Stanley -4.78% 52.72%
Blackstone, Inc. 10.07% 118.70%
The Charles Schwab Corp. 11.49% 57.62%

Statement Summary

as of 4:10 ET PM 12/03/2021
Total Assets (MRQ) 2.4 T
Total Liabilities (MRQ) 2.2 T
Shareholders’ Equity (MRQ) 201.6 B
Total Revenue (Annual) 19.4 B
Net Income (Annual) 4.6 B

Earnings And Estimates

as of 4:10 ET PM 12/03/2021

Current Qtr EPS Estimate 1.83
Current FY EPS Estimate 10.53
Long Term EPS Growth Estimate 21.86
Next Expected Earnings Date 1/14/2022

C vs S&P 500

as of 12/03/2021
Relative To
S&P 500
C
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:10 ET PM 12/03/2021
Fiscal Quarter Estimate Actual Surprise
09/2021 1.71 2.15 +26.04%
06/2021 1.97 2.85 +44.78%
03/2021 2.60 3.62 +39.38%
12/2020 1.34 2.08 +54.93%
09/2020 0.91 1.40 +54.10%
06/2020 0.36 0.50 +38.16%
03/2020 1.09 1.05 -3.49%
12/2019 1.81 2.15 +18.64%

Financial Strength

as of 4:10 ET PM 12/03/2021
Pre-Tax Margin 30.21
Net Margin 48.37
Operating Margin 0.00
Return On Equity 11.78
Return On Assets 1.01
Inventory Turnover (TTM) 0.00
Sales Growth (MRQ) 0.20

Ratios

as of 4:10 PM ET 12/03/2021
Price/Earnings (TTM) 5.87
Price/Book (MRQ) 0.68
Price/Cash Flow (TTM) 2.16
Book Value (MRQ) 92.17
Quick Ratio (MRQ) 0.00
Current Ratio (MRQ) 1.46
Total Debt/Equity (MRQ) 2.49

Short Interest

as of 4:10 PM ET 12/06/2021
% Short - 1.83%
% Remaining Float - 98.17%
Current Last Month
Short Interest Date 11/15/2021 10/29/2021
Short Interest Shares 37,063,691 37,460,852
Short Interest Ratio 1.8 2.1
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:10 ET PM 12/03/2021
Current Qtr
(12/2021)
Next Qtr
(03/2022)
Consensus Estimate $1.83 $2.15
# of Estimates 20 16
High Estimate $2.05 $2.50
Low Estimate $1.62 $1.70
Year Ago EPS $2.09 $3.64
Year Over Year Growth Estimate -12.18% -40.99%
Current Yr
(12/2021)
Next Yr
(12/2022)
Consensus Estimate $10.53 $7.97
# of Estimates 23 23
High Estimate $10.95 $8.83
Low Estimate $10.30 $6.30
Year Ago EPS $4.87 $10.53
Year Over Year Growth Estimate 116.32% -24.37%
Current Qtr
(12/2021)
Next Qtr
(03/2022)
Current Year
(12/2021)
Next Year
(12/2022)
Consensus Estimate $1.83 $2.15 $10.53 $7.97
# of Estimates 20 16 23 23
High Estimate $2.05 $2.50 $10.95 $8.83
Low Estimate $1.62 $1.70 $10.30 $6.30
Year Ago EPS $2.09 $3.64 $4.87 $10.53
Year Over Year Growth Estimate -12.18% -40.99% 116.32% -24.37%

Insider Information Summary

as of 11/30/2021
% Insiders - 0.17%
% Remaining Total Shares - 99.83%
Current 1 Month
Net Insider Transaction -49.14 K -37.08 K
Shares Bought 5.52 K 5.52 K
Shares Sold 54.66 K 42.60 K

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Glaxo, IP and PetMed Poised to Go Higher

GlaxoSmithKline, Vir Biotechnology Say COVID Therapy Effective Against Omicron Variant

GlaxoSmithKline and its U.S. partner, Vir Biotechnology, said Tuesday that their COVID antibody is effective against all mutations of the new Omicron variant.

SpaceX founder and chief engineer Elon Musk (seen in January last year) joined Clubhouse on Monday, the same day stock rocketed by 30 per cent on Friday's closing price. Photo: Reuters

Tesla Stock Gains After Elon Musk Disses Biden's EV Bill

Tesla shares are set to snap a four-day losing streak after Elon Musk says Congress should not approve the Biden infrastructure bill that includes EV subsidies.

intel (4)

Intel Stock Surges On Plans For Potential $50 Billion Mobileye IPO

Intel plans to list Mobileye, the self-driving car division is purchased in 2017, sometime next year in a deal that could value the group at around $50 billion.

Omicron COVID-19 Lead

Investor Angst Over Omicron is Easing

James 'Rev Shark" Deporre says investors shouldn't ignore the latest variant.

Wall Street Diversity Lead

Intel, Samsung, Omicron, Tesla and Surging Stock Markets - 5 Things You Must Know

Stocks futures extend gains as Omicron risks fade, Glaxo and Vir Bio say COVID therapy effective against variant; Intel plans potential $50 billion Mobileye IPO; Samsung merges phone and electronics division in major restructuring and Elon Musk says Biden's EV incentives shouldn't pass congress.

Tech Companies Lead

Tech Stocks are Facing a Reckoning After Months of Rapid Gains

But some chip names still have relatively low valuations.

Wall Street NYSE Lead

Cramer's Mad Money Recap 12/6: Earnings, Covid and Interest Rates

Jim Cramer says investors should ignore pre-market jitters and focus on the three things the market really cares about.

Devin Nunes To Resign From Congress To Become CEO Of Trump's Media Company

Devin Nunes will be resigning from Congress to take a role at former President Donald Trump's new media company.

Costco Store Lead

Stocks of the Week: Costco, AMC, Meta and More

Earnings reports are still coming in for some Wall Street favorites.